Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.

Abstract

Background Post-partum depression is a serious mood disorder in women that might be triggered by peripartum fluctuations in reproductive hormones. This phase 2 study investigated brexanolone (USAN; formerly SAGE-547 injection), an intravenous formulation of allopregnanolone, a positive allosteric modulator of γ-aminobutyric acid (GABA A ) receptors, for the treatment of post-partum depression. Methods For this double-blind, randomised, placebo-controlled trial, we enrolled self-referred or physician-referred female inpatients (≤6 months post partum) with severe post-partum depression (Hamilton Rating Scale for Depression [HAM-D] total score ≥26) in four hospitals in the USA. Eligible women were randomly assigned (1:1), via a computer-generated randomisation program, to receive either a single, continuous intravenous dose of brexanolone or placebo for 60 h. Patients and investigators were masked to treatment assignments. The primary efficacy endpoint was the change from baseline in the 17-item HAM-D total score at 60 h, assessed in all randomised patients who started infusion of study drug or placebo and who had a completed baseline HAM-D assessment and at least one post-baseline HAM-D assessment. Patients were followed up until day 30. This trial is registered with ClinicalTrials.gov, number NCT02614547. Findings This trial was done between Dec 15, 2015 (first enrolment), and May 19, 2016 (final visit of the last enrolled patient). 21 women were randomly assigned to the brexa…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(17)31264-3

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 54 references

Cited by

See all 482

Metadata

Authors
Kanes, S., Colquhoun, H., Gunduz-Bruce, H., Raines, S., Arnold, R., Schacterle, A., Doherty, J., Epperson, C. N., Deligiannidis, K. M., Riesenberg, R., Hoffmann, E., Rubinow, D., Jonas, J., Paul, S., & Meltzer-Brody, S.
Affiliations
  • Sage Therapeutics (United States) (US)
  • University of Pennsylvania (US)
  • University of Massachusetts Chan Medical School (US)
  • Atlanta Center for Medical Research (US)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
Meltzer-Brody, Samantha
Venue
The Lancet
Publisher
Elsevier BV
Published
2017-07
Volume
390
Issue
10093
Pages
480-489
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2626607634
Cited by
479
References
54
Citations by year
2026: 23 · 2025: 43 · 2024: 55 · 2023: 50 · 2022: 35 · 2021: 80 · 2020: 74 · 2019: 69 · 2018: 35 · 2017: 14
FWCI
49.31
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sage Therapeutics
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy-related medical research
Keywords
postpartum depression, brexanolone, allopregnanolone, intravenous infusion, severe depression, maternal mental health, adverse events, dizziness, sleep disorders, antidepressant efficacy, Hamilton Depression Rating Scale, peripartum
MeSH terms
Adult, Antidepressive Agents, Double-Blind Method, Drug Combinations, Female, Humans, Infusions, Intravenous, Pregnanolone, Psychiatric Status Rating Scales, Treatment Outcome, Depression, Postpartum, beta-Cyclodextrins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(17)31264-3
The paper
Kanes, S., Colquhoun, H., Gunduz-Bruce, H., Raines, S., Arnold, R., Schacterle, A., Doherty, J., Epperson, C. N., Deligiannidis, K. M., Riesenberg, R., Hoffmann, E., Rubinow, D., Jonas, J., Paul, S., & Meltzer-Brody, S. (2017). Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(17)31264-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.